Latest filing published 25 Jun 2020 for Cipher Pharmaceuticals Inc., €8,880.
Nadine Jutlah appears in our data through filings on Cipher Pharmaceuticals Inc. shares, published by SEDI. The record holds 4 filings, for trades running from 1 April 2019 to 23 June 2020.
Sales make up the whole of the open-market record (1 sale, €8,880). Outside the open market, there are 1 share grant and 2 option exercises. So far in 2020, the count stands at no purchases and 1 sale.
The record was last updated on 25 June 2020 with an open-market sale (€8,880) in Cipher Pharmaceuticals Inc. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations